InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: antihama post# 2468

Saturday, 01/19/2019 8:54:03 AM

Saturday, January 19, 2019 8:54:03 AM

Post# of 3283
Thanks. Makes sense. FDA wanted data on 30 patients ORR and DOR as I recall. This number of censored patients may have resulted in the FDA saying you have not provided enough data.

In any event we move forward. I agree there should be less censored patients in the Zenith20 trial. Hopefully, SPPI has a good handle on what the FDA expects for approval.

We always have to hope SPPI has their act together.